{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:04:55Z","timestamp":1789434295101,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03910-3","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:55:58Z","timestamp":1782712558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hereditary spastic paraplegia (HSP) gene 11 (Spg11) attenuates lipid accumulation in myeloid cells and neuroinflammation in the midbrain without affecting \u03b1-synuclein pathology"],"prefix":"10.1186","volume":"23","author":[{"given":"Margaret","family":"Hayne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Lipka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawaun A.","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison L.","family":"Soung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Adrian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumitra","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Ngu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oded","family":"Foreman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Kaminker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper C.","family":"Hoogenraad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"3910_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(83)92879-9","volume":"321","author":"AE Harding","year":"1983","unstructured":"Harding AE, Classification of the, hereditary ataxias and paraplegias. Lancet. 1983;321:1151\u20135.","journal-title":"Lancet"},{"key":"3910_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/00019052-200108000-00005","volume":"14","author":"CME Tallaksen","year":"2001","unstructured":"Tallaksen CME, D\u00fcrr A, Brice A. Recent advances in hereditary spastic paraplegia. Curr Opin Neurol. 2001;14:457.","journal-title":"Curr Opin Neurol"},{"key":"3910_CR3","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3390\/ijms23031697","volume":"23","author":"A Meyyazhagan","year":"2022","unstructured":"Meyyazhagan A, Orlacchio A. Hereditary Spastic Paraplegia: An Update. Int J Mol Sci. 2022;23:1697.","journal-title":"Int J Mol Sci"},{"key":"3910_CR4","doi-asserted-by":"publisher","first-page":"175628642514065","DOI":"10.1177\/17562864251406589","volume":"19","author":"L Cipriano","year":"2026","unstructured":"Cipriano L, Angelini C, Maria Santorelli F. Hereditary spastic paraplegia: from decades of therapy to future innovations. Ther Adv Neurol Disord. 2026;19:17562864251406589.","journal-title":"Ther Adv Neurol Disord"},{"key":"3910_CR5","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/brain\/aww111","volume":"139","author":"E Kara","year":"2016","unstructured":"Kara E, et al. Genetic and phenotypic characterization of complex hereditary spastic paraplegia. Brain J Neurol. 2016;139:1904\u201318.","journal-title":"Brain J Neurol"},{"key":"3910_CR6","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.expneurol.2014.06.011","volume":"261","author":"T Lo Giudice","year":"2014","unstructured":"Lo Giudice T, Lombardi F, Santorelli FM, Kawarai T, Orlacchio A. Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms. Exp Neurol. 2014;261:518\u201339.","journal-title":"Exp Neurol"},{"key":"3910_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10048-023-00717-9","volume":"24","author":"D Galatolo","year":"2023","unstructured":"Galatolo D, et al. Power of NGS-based tests in HSP diagnosis: analysis of massively parallel sequencing in clinical practice. Neurogenetics. 2023;24:147\u201360.","journal-title":"Neurogenetics"},{"key":"3910_CR8","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/brain\/awaa099","volume":"143","author":"T Pozner","year":"2020","unstructured":"Pozner T, Regensburger M, Engelhorn T, Winkler J, Winner B. Janus-faced spatacsin (SPG11): involvement in neurodevelopment and multisystem neurodegeneration. Brain J Neurol. 2020;143:2369\u201379.","journal-title":"Brain J Neurol"},{"key":"3910_CR9","doi-asserted-by":"publisher","first-page":"1198728","DOI":"10.3389\/fneur.2023.1198728","volume":"14","author":"Y-R Kang","year":"2023","unstructured":"Kang Y-R, et al. Clinical analysis in patients with SPG11 hereditary spastic paraplegia. Front Neurol. 2023;14:1198728.","journal-title":"Front Neurol"},{"key":"3910_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3174\/ajnr.A5935","volume":"40","author":"B Pascual","year":"2019","unstructured":"Pascual B, et al. Ears of the Lynx\u2019 MRI Sign Is Associated with SPG11 and SPG15 Hereditary Spastic Paraplegia. AJNR Am J Neuroradiol. 2019;40:199\u2013203.","journal-title":"AJNR Am J Neuroradiol"},{"key":"3910_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1552-6569.2008.00327.x","volume":"19","author":"M Riverol","year":"2009","unstructured":"Riverol M, et al. Forceps minor region signal abnormality \u2018ears of the lynx\u2019: an early MRI finding in spastic paraparesis with thin corpus callosum and mutations in the spatacsin gene (SPG11) on chromosome 15. J Neuroimaging Off J Am Soc Neuroimaging. 2009;19:52\u201360.","journal-title":"J Neuroimaging Off J Am Soc Neuroimaging"},{"key":"3910_CR12","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.nicl.2018.05.031","volume":"19","author":"I Faber","year":"2018","unstructured":"Faber I, et al. SPG11 mutations cause widespread white matter and basal ganglia abnormalities, but restricted cortical damage. NeuroImage Clin. 2018;19:848\u201357.","journal-title":"NeuroImage Clin"},{"key":"3910_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.conb.2021.07.005","volume":"72","author":"F Darios","year":"2022","unstructured":"Darios F, Coarelli G, Durr A. Genetics in hereditary spastic paraplegias: Essential but not enough. Curr Opin Neurobiol. 2022;72:8\u201314.","journal-title":"Curr Opin Neurobiol"},{"key":"3910_CR14","doi-asserted-by":"publisher","first-page":"e8395","DOI":"10.1016\/j.neurobiolaging.2011.11.012","volume":"33","author":"H Daoud","year":"2012","unstructured":"Daoud H, et al. Exome sequencing reveals SPG11 mutations causing juvenile ALS. Neurobiol Aging. 2012;33:e8395\u20139.","journal-title":"Neurobiol Aging"},{"key":"3910_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s00415-009-0083-3","volume":"256","author":"M Anheim","year":"2009","unstructured":"Anheim M, et al. SPG11 spastic paraplegia. A new cause of juvenile parkinsonism. J Neurol. 2009;256:104\u20138.","journal-title":"J Neurol"},{"key":"3910_CR16","first-page":"1723","volume":"139","author":"PS Denora","year":"2016","unstructured":"Denora PS, et al. Motor neuron degeneration in spastic paraplegia 11 mimics amyotrophic lateral sclerosis lesions. Brain. 2016;139:1723\u201334.","journal-title":"Brain"},{"key":"3910_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/15548627.2018.1507438","volume":"15","author":"C Vantaggiato","year":"2019","unstructured":"Vantaggiato C, et al. ZFYVE26\/SPASTIZIN and SPG11\/SPATACSIN mutations in hereditary spastic paraplegia types AR-SPG15 and AR-SPG11 have different effects on autophagy and endocytosis. Autophagy. 2019;15:34\u201357.","journal-title":"Autophagy"},{"key":"3910_CR18","doi-asserted-by":"publisher","first-page":"e1005454","DOI":"10.1371\/journal.pgen.1005454","volume":"11","author":"R-E Varga","year":"2015","unstructured":"Varga R-E, et al. In Vivo Evidence for Lysosome Depletion and Impaired Autophagic Clearance in Hereditary Spastic Paraplegia Type SPG11. PLoS Genet. 2015;11:e1005454.","journal-title":"PLoS Genet"},{"key":"3910_CR19","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s42003-019-0615-z","volume":"2","author":"M Boutry","year":"2019","unstructured":"Boutry M, et al. Loss of spatacsin impairs cholesterol trafficking and calcium homeostasis. Commun Biol. 2019;2:380.","journal-title":"Commun Biol"},{"key":"3910_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.nbd.2017.02.007","volume":"102","author":"J Branchu","year":"2017","unstructured":"Branchu J, et al. Loss of spatacsin function alters lysosomal lipid clearance leading to upper and lower motor neuron degeneration. Neurobiol Dis. 2017;102:21\u201337.","journal-title":"Neurobiol Dis"},{"key":"3910_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/acn3.64","volume":"1","author":"B Renvois\u00e9","year":"2014","unstructured":"Renvois\u00e9 B, et al. Lysosomal abnormalities in hereditary spastic paraplegia types SPG15 and SPG11. Ann Clin Transl Neurol. 2014;1:379\u201389.","journal-title":"Ann Clin Transl Neurol"},{"key":"3910_CR22","doi-asserted-by":"publisher","first-page":"5249","DOI":"10.1172\/JCI77598","volume":"124","author":"J Chang","year":"2014","unstructured":"Chang J, Lee S, Blackstone C. Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation. J Clin Invest. 2014;124:5249\u201362.","journal-title":"J Clin Invest"},{"key":"3910_CR23","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1091\/mbc.e13-03-0170","volume":"24","author":"J Hirst","year":"2013","unstructured":"Hirst J, et al. Interaction between AP-5 and the hereditary spastic paraplegia proteins SPG11 and SPG15. Mol Biol Cell. 2013;24:2558\u201369.","journal-title":"Mol Biol Cell"},{"key":"3910_CR24","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1007\/s10072-023-07044-9","volume":"44","author":"S Aloisio","year":"2023","unstructured":"Aloisio S, Satolli S, Bellini G, Lopriore P. Parkinsonism in complex neurogenetic disorders: lessons from hereditary dementias, adult-onset ataxias and spastic paraplegias. Neurol Sci. 2023;44:3379\u201388.","journal-title":"Neurol Sci"},{"key":"3910_CR25","doi-asserted-by":"publisher","first-page":"106564","DOI":"10.1016\/j.nbd.2024.106564","volume":"199","author":"M Fortier","year":"2024","unstructured":"Fortier M, et al. Decreasing ganglioside synthesis delays motor and cognitive symptom onset in Spg11 knockout mice. Neurobiol Dis. 2024;199:106564.","journal-title":"Neurobiol Dis"},{"key":"3910_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/mdc3.12144","volume":"2","author":"S Wijemanne","year":"2015","unstructured":"Wijemanne S, Shulman JM, Jimenez-Shahed J, Curry D, Jankovic J. SPG11 Mutations Associated With a Complex Phenotype Resembling Dopa-Responsive Dystonia. Mov Disord Clin Pract. 2015;2:149\u201354.","journal-title":"Mov Disord Clin Pract"},{"key":"3910_CR27","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1002\/mds.23221","volume":"25","author":"C Pais\u00e1n-Ruiz","year":"2010","unstructured":"Pais\u00e1n-Ruiz C, et al. Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov Disord Off J Mov Disord Soc. 2010;25:1791\u2013800.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"3910_CR28","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/mds.23552","volume":"26","author":"A Guidubaldi","year":"2011","unstructured":"Guidubaldi A, et al. Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levodopa-responsive Parkinsonism. Mov Disord Off J Mov Disord Soc. 2011;26:553\u20136.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"3910_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ymgme.2012.05.020","volume":"107","author":"A Vanderver","year":"2012","unstructured":"Vanderver A, et al. Neurotransmitter abnormalities and response to supplementation in SPG11. Mol Genet Metab. 2012;107:229\u201333.","journal-title":"Mol Genet Metab"},{"key":"3910_CR30","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1002\/mds.27491","volume":"33","author":"I Faber","year":"2018","unstructured":"Faber I, et al. SPG11-related parkinsonism: Clinical profile, molecular imaging and l-dopa response. Mov Disord. 2018;33:1650\u20136.","journal-title":"Mov Disord"},{"key":"3910_CR31","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mds.20800","volume":"21","author":"F Micheli","year":"2006","unstructured":"Micheli F, Cers\u00f3simo MG. Z\u00fa\u00f1iga Ram\u00edrez, C. Hereditary spastic paraplegia associated with dopa-responsive parkinsonism. Mov Disord. 2006;21:716\u20137.","journal-title":"Mov Disord"},{"key":"3910_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12883-021-02514-z","volume":"22","author":"M Hayakawa","year":"2022","unstructured":"Hayakawa M, et al. An autopsied case report of spastic paraplegia with thin corpus callosum carrying a novel mutation in the SPG11 gene: widespread degeneration with eosinophilic inclusions. BMC Neurol. 2022;22:2.","journal-title":"BMC Neurol"},{"key":"3910_CR33","doi-asserted-by":"publisher","first-page":"114119","DOI":"10.1016\/j.expneurol.2022.114119","volume":"355","author":"M H\u00f6rner","year":"2022","unstructured":"H\u00f6rner M, et al. CNS-associated T-lymphocytes in a mouse model of Hereditary Spastic Paraplegia type 11 (SPG11) are therapeutic targets for established immunomodulators. Exp Neurol. 2022;355:114119.","journal-title":"Exp Neurol"},{"key":"3910_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00401-023-02675-w","volume":"147","author":"L Krumm","year":"2024","unstructured":"Krumm L, et al. Neuroinflammatory disease signatures in SPG11-related hereditary spastic paraplegia patients. Acta Neuropathol (Berl). 2024;147:28.","journal-title":"Acta Neuropathol (Berl)"},{"key":"3910_CR35","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.1038\/s41467-023-41891-6","volume":"14","author":"M Adrian","year":"2023","unstructured":"Adrian M, et al. Polarized microtubule remodeling transforms the morphology of reactive microglia and drives cytokine release. Nat Commun. 2023;14:6322.","journal-title":"Nat Commun"},{"key":"3910_CR36","doi-asserted-by":"publisher","first-page":"105494","DOI":"10.1016\/j.nbd.2021.105494","volume":"159","author":"R Brendza","year":"2021","unstructured":"Brendza R, et al. Genetic ablation of Gpnmb does not alter synuclein-related pathology. Neurobiol Dis. 2021;159:105494.","journal-title":"Neurobiol Dis"},{"key":"3910_CR37","doi-asserted-by":"publisher","first-page":"105969","DOI":"10.1016\/j.nbd.2022.105969","volume":"177","author":"R Brendza","year":"2023","unstructured":"Brendza R, et al. Anti-\u03b1-synuclein c-terminal antibodies block PFF uptake and accumulation of phospho-synuclein in preclinical models of Parkinson\u2019s disease. Neurobiol Dis. 2023;177:105969.","journal-title":"Neurobiol Dis"},{"key":"3910_CR38","doi-asserted-by":"publisher","first-page":"e70274","DOI":"10.1371\/journal.pone.0070274","volume":"8","author":"KL Paumier","year":"2013","unstructured":"Paumier KL, et al. Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson\u2019s disease. PLoS ONE. 2013;8:e70274.","journal-title":"PLoS ONE"},{"key":"3910_CR39","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, et al. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron. 2002;34:521\u201333.","journal-title":"Neuron"},{"key":"3910_CR40","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk KC, et al. Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice. J Exp Med. 2012;209:975\u201386.","journal-title":"J Exp Med"},{"key":"3910_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cellimm.2018.01.020","volume":"330","author":"A Remmerie","year":"2018","unstructured":"Remmerie A, Scott CL. Macrophages and lipid metabolism. Cell Immunol. 2018;330:27\u201342.","journal-title":"Cell Immunol"},{"key":"3910_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1146\/annurev-neuro-091922-034237","volume":"46","author":"G Saher","year":"2023","unstructured":"Saher G. Cholesterol Metabolism in Aging and Age-Related Disorders. Annu Rev Neurosci. 2023;46:59\u201378.","journal-title":"Annu Rev Neurosci"},{"key":"3910_CR43","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","volume":"11","author":"E Sidransky","year":"2012","unstructured":"Sidransky E, Lopez G. The link between the GBA gene and parkinsonism. Lancet Neurol. 2012;11:986\u201398.","journal-title":"Lancet Neurol"},{"key":"3910_CR44","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/brain\/awab371","volume":"145","author":"C Galvagnion","year":"2022","unstructured":"Galvagnion C, et al. Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote \u03b1-synuclein aggregation. Brain J Neurol. 2022;145:1038\u201351.","journal-title":"Brain J Neurol"},{"key":"3910_CR45","first-page":"773","volume":"32","author":"LJ Smith","year":"2023","unstructured":"Smith LJ, Bolsinger MM, Chau K-Y, Gegg ME, Schapira AH. V. The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines. Hum Mol Genet. 2023;32:773\u201389.","journal-title":"Hum Mol Genet"},{"key":"3910_CR46","doi-asserted-by":"publisher","first-page":"10328","DOI":"10.1073\/pnas.1604645113","volume":"113","author":"P Flagmeier","year":"2016","unstructured":"Flagmeier P, et al. Mutations associated with familial Parkinson\u2019s disease alter the initiation and amplification steps of \u03b1-synuclein aggregation. Proc Natl Acad Sci U S A. 2016;113:10328\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3910_CR47","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nchembio782","volume":"2","author":"DA Bosco","year":"2006","unstructured":"Bosco DA, et al. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Nat Chem Biol. 2006;2:249\u201353.","journal-title":"Nat Chem Biol"},{"key":"3910_CR48","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K Imamura","year":"2003","unstructured":"Imamura K, et al. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta Neuropathol (Berl). 2003;106:518\u201326.","journal-title":"Acta Neuropathol (Berl)"},{"key":"3910_CR49","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13024-019-0314-8","volume":"14","author":"M-E Tremblay","year":"2019","unstructured":"Tremblay M-E, Cookson MR, Civiero L. Glial phagocytic clearance in Parkinson\u2019s disease. Mol Neurodegener. 2019;14:16.","journal-title":"Mol Neurodegener"},{"key":"3910_CR50","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1038\/s41598-025-86337-9","volume":"15","author":"L Toupenet Marchesi","year":"2025","unstructured":"Toupenet Marchesi L, et al. Transcriptomic analysis reinforces the implication of spatacsin in neuroinflammation and neurodevelopment. Sci Rep. 2025;15:2370.","journal-title":"Sci Rep"},{"key":"3910_CR51","doi-asserted-by":"publisher","unstructured":"Afzal MA, et al. Hyperactivity of the non-canonical inflammasome in SPG11 and SPG48. eBioMedicine. 2025;121. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105985.","DOI":"10.1016\/j.ebiom.2025.105985"},{"key":"3910_CR52","doi-asserted-by":"publisher","first-page":"e20232357","DOI":"10.1084\/jem.20232357","volume":"222","author":"A Frolov","year":"2025","unstructured":"Frolov A, et al. Microglia and CD8\u2009+\u2009T cell activation precede neuronal loss in a murine model of spastic paraplegia 15. J Exp Med. 2025;222:e20232357.","journal-title":"J Exp Med"},{"key":"3910_CR53","doi-asserted-by":"publisher","first-page":"102070","DOI":"10.1016\/j.pneurobio.2021.102070","volume":"202","author":"S Ghosh","year":"2021","unstructured":"Ghosh S, et al. \u03b1-synuclein aggregates induce c-Abl activation and dopaminergic neuronal loss by a feed-forward redox stress mechanism. Prog Neurobiol. 2021;202:102070.","journal-title":"Prog Neurobiol"},{"key":"3910_CR54","first-page":"100131","volume":"3","author":"H Barzekar","year":"2023","unstructured":"Barzekar H, et al. Multiclass semantic segmentation mediated neuropathological readout in Parkinson\u2019s disease. Neurosci Inf. 2023;3:100131.","journal-title":"Neurosci Inf"},{"key":"3910_CR55","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/s41592-022-01663-4","volume":"19","author":"M Pachitariu","year":"2022","unstructured":"Pachitariu M, Stringer C. Cellpose 2.0: how to train your own model. Nat Methods. 2022;19:1634\u201341.","journal-title":"Nat Methods"},{"key":"3910_CR56","doi-asserted-by":"publisher","first-page":"e70221","DOI":"10.1371\/journal.pone.0070221","volume":"8","author":"M Veta","year":"2013","unstructured":"Veta M, et al. Automatic Nuclei Segmentation in H&E Stained Breast Cancer Histopathology Images. PLoS ONE. 2013;8:e70221.","journal-title":"PLoS ONE"},{"key":"3910_CR57","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels P, Magnusson M, Lundin S, K\u00e4ller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinforma Oxf Engl. 2016;32:3047\u20138.","journal-title":"Bioinforma Oxf Engl"},{"key":"3910_CR58","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884\u201390.","journal-title":"Bioinformatics"},{"key":"3910_CR59","doi-asserted-by":"crossref","unstructured":"Chen S. Ultrafast one-pass FASTQ data preprocessing, quality control, and deduplication using fastp. iMeta. 2023;2:e107.","DOI":"10.1002\/imt2.107"},{"key":"3910_CR60","unstructured":"Pau G, et al. HTSeqGenie: a software package to analyse high-throughput sequencing experiments. 2017. https:\/\/www.rdocumentation.org\/packages\/HTSeqGenie\/versions\/4.2.0\/topics\/HTSeqGenie."},{"key":"3910_CR61","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","volume":"4","author":"S Durinck","year":"2009","unstructured":"Durinck S, Spellman PT, Birney E, Huber W. Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomaRt. Nat Protoc. 2009;4:1184\u201391.","journal-title":"Nat Protoc"},{"key":"3910_CR62","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law CW, Chen Y, Shi W, Smyth G. K. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15:R29.","journal-title":"Genome Biol"},{"key":"3910_CR63","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"3910_CR64","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32:2847\u20139.","journal-title":"Bioinformatics"},{"key":"3910_CR65","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","volume":"19","author":"S Xu","year":"2024","unstructured":"Xu S, et al. Using clusterProfiler to characterize multiomics data. Nat Protoc. 2024;19:3292\u2013320.","journal-title":"Nat Protoc"},{"key":"3910_CR66","doi-asserted-by":"publisher","unstructured":"Korotkevich G et al. Fast gene set enrichment analysis. 2021. 060012 Preprint at https:\/\/doi.org\/10.1101\/060012.","DOI":"10.1101\/060012"},{"key":"3910_CR67","doi-asserted-by":"publisher","first-page":"115382","DOI":"10.1016\/j.celrep.2025.115382","volume":"44","author":"OI Kahn","year":"2025","unstructured":"Kahn OI, et al. Secreted neurofilament light chain after neuronal damage induces myeloid cell activation and neuroinflammation. Cell Rep. 2025;44:115382.","journal-title":"Cell Rep"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03910-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03910-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03910-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:02:05Z","timestamp":1789434125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03910-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3910"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03910-3","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal studies were approved by Genentech\u2019s Institutional Animal Care and Use Committee, in accordance with guidelines that adhere to and exceed state and national ethical regulations for animal care and use in research.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, no human subjects were used in this study.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors are employees of Genentech, Inc., a member of the Roche group. The authors declare that they have no additional conflict of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"313"}}